Theratechnologies Inc.

NASDAQ: THTX · Real-Time Price · USD
2.63
0.04 (1.54%)
At close: Jun 03, 2025, 3:59 PM
2.64
0.57%
Pre-market: Jun 04, 2025, 05:42 AM EDT

Theratechnologies Revenue Breakdown

Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021 Nov 30, 2020 Nov 30, 2019
EGRIFTA Revenue 60.15M 53.7M 50.45M 43.01M 35.4M 35.52M
EGRIFTA Revenue Growth +12.00% +6.44% +17.31% +21.50% -0.34% n/a
TROGARZO Net Sales Revenue 25.72M n/a n/a n/a n/a n/a
TROGARZO Net Sales Revenue Growth n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021 Nov 30, 2020 Nov 30, 2019
Europe Revenue 62K 286K 78.74M 68.1M 65.45M 62.92M
Europe Revenue Growth -78.32% -99.64% +15.63% +4.04% +4.03% n/a
United States Revenue 85.8M 81.39M n/a n/a n/a n/a
United States Revenue Growth +5.42% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020 May 31, 2020 Feb 29, 2020 Nov 30, 2019 Aug 31, 2019 May 31, 2019 Feb 28, 2019 Nov 30, 2018 Aug 31, 2018 May 31, 2018 Feb 28, 2018 Nov 30, 2017 Aug 31, 2017 May 31, 2017 Feb 28, 2017 Nov 30, 2016 Aug 31, 2016 May 31, 2016 Feb 29, 2016 Nov 30, 2015 Aug 31, 2015 May 31, 2015 Feb 28, 2015
Selling, General, and Administrative Revenue 10.7M 12.1M 9.25M 9.09M 8.85M 10.49M 10.44M 10.2M 11.27M 11.77M 12.61M 20.19M 12.18M 11.73M 11.29M 10.79M 9.72M 9.79M 9.72M 10.65M 8.93M 10.93M 8.16M 8.76M 6.96M 7.1M 6.67M 7.24M 6.52M 7.42M 6.7M 6.58M 3.77M 3.83M 3.77M 3.39M 3.68M 4.13M 3.31M 2.84M 2.83M
Selling, General, and Administrative Revenue Growth -11.59% +30.79% +1.76% +2.74% -15.60% +0.47% +2.38% -9.51% -4.24% -6.72% -37.54% +65.86% +3.79% +3.90% +4.68% +10.96% -0.68% +0.65% -8.67% +19.21% -18.30% +33.94% -6.80% +25.73% -1.89% +6.40% -7.81% +11.05% -12.21% +10.78% +1.82% +74.77% -1.75% +1.63% +11.18% -7.95% -10.79% +24.74% +16.59% +0.49% n/a
Research and Development Revenue 2.97M 5.88M 2.61M 3.67M 3.71M 5.23M 5.4M 10.39M 9.36M 9.46M 8.43M 11.12M 8M 8.75M 8.39M 6.51M 4.91M 6.89M 4.38M 3.62M 3.42M 3.88M 2.15M 2.29M 2.53M 2.06M 2.13M 1.9M 1.9M 2.4M 2.47M 2.71M 1.52M 1.34M 1.36M 1.63M 1.39M 1.12M 1.11M 1.11M 895.11K
Research and Development Revenue Growth -49.54% +125.27% -28.88% -1.13% -28.96% -3.09% -48.06% +11.04% -1.05% +12.23% -24.25% +38.97% -8.50% +4.27% +28.87% +32.62% -28.82% +57.46% +20.90% +5.94% -11.81% +80.16% -5.82% -9.58% +22.49% -3.15% +12.28% -0.37% -20.61% -3.02% -8.59% +77.86% +13.67% -1.35% -16.76% +17.04% +23.96% +1.24% -0.08% +24.05% n/a
Sales and Marketing Revenue 6.47M 7.04M 6.31M 6.37M 5.7M 6.75M 6.73M 6.48M 6.81M 7.81M 8.4M 15.37M 7.81M 8.19M 7.66M 6.9M 6.16M 6.53M 7.03M 6.94M 6.36M 7.67M 6.39M 6.97M 5.45M 5.23M 5.19M 5.96M 5.31M 6.19M 5.67M 5.32M 2.84M 2.75M 2.79M 2.54M 2.88M 3.23M 2.66M 2.03M 2.01M
Sales and Marketing Revenue Growth -8.15% +11.69% -0.94% +11.68% -15.52% +0.30% +3.84% -4.92% -12.74% -7.08% -45.33% +96.89% -4.71% +7.00% +10.95% +12.07% -5.73% -7.02% +1.21% +9.12% -17.10% +20.10% -8.36% +27.97% +4.11% +0.85% -12.89% +12.10% -14.14% +9.26% +6.41% +87.70% +3.09% -1.41% +9.65% -11.76% -10.60% +21.35% +31.00% +0.93% n/a